|Description||LOE 908 hydrochloride is a broad spectrum cation channel blocker. It can inhibit several cation channels including store-operated calcium channels, voltage-operated calcium channels and so on. LOE 908 hydrochloride can reduce cortical infarct size and improve neurological outcome following middle cerebral artery occlusion.|
|Purity||≥98% by HPLC|
|Synonyms||LOE 908 hydrochloride; LOE908 hydrochloride; LOE-908 hydrochloride; 3,4-Dihydro-6,7-dimethoxy-α-phenyl-N,N-bis[2-(2,3,4-trimethoxyphenyl)ethyl]-1-isoquinolineacetamide hydrochloride|
Echinacoside, a natural polyphenolic compound, has various kinds of pharmacological activities, such as antioxidative, anti-inflammatory, neuroprotective, hepat...
FR-64822 is a novel non-opioid antinociceptive compound. It has antinociceptive activities in a variety of assays in mice and rats. It also has a strong antinoc...
K-7174, one of proteasome inhibitory homopiperazine derivatives, exhibits a therapeutic effect, which is stronger when administered orally than intravenously, w...
ProINDY, the prodrug form of INDY, is a cell permeable ATP-competitive DYRK1A/B inhibitor.
Benfluorex hydrochloride is a known hypolipidaemic agent with possible glucose-lowering effects. Several clinical studies have shown a reduction in triglyceride...
Azaserine is a naturally occurring serine derivative diazo compound with antineoplastic properties, Azaserine functions as a purine antagonist and glutamine ana...
KLS-13019, an azetidine derivative, could be a neuroprotective agent and has been found to exbihit much more effective than cannabidiol.
Moguisteine is a novel peripheral nonnarcotic antitussive agent that has proved to be as active as codeine in several experimental models of induced cough in gu...